Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Fuchs

Showing results (81-90 of 172) with videos related to

Pageof 18
Sort By:
Cancer|December 12, 2003
Complications in long-term survivors of Ewing sarcomaBruno Fuchs, Richard G Valenzuela, Carrie Inwards, et al.
BMC Cancer|August 3, 2014
ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2Ram Mohan Ram Kumar, Michael M Betz, Bernhard Robl, et al.
Molecular Carcinogenesis|August 9, 2007
Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasisKnut Husmann, Roman Muff, Marc E Bolander, et al.
Translational Oncology|April 28, 2017
Evaluation of F8-TNF-α in Models of Early and Progressive Metastatic OsteosarcomaBernhard Robl, Sander Martijn Botter, Aleksandar Boro, et al.
Clinical Orthopaedics and Related Research|October 16, 2008
Osteosarcoma of the pelvis: outcome analysis of surgical treatmentBruno Fuchs, Nathan Hoekzema, Dirk R Larson, et al.
Sarcoma|December 6, 2012
Genes regulated in metastatic osteosarcoma: evaluation by microarray analysis in four human and two mouse cell line systemsRoman Muff, Ram Mohan Ram Kumar, Sander M Botter, et al.
Oncology|December 23, 2014
RANK ligand blockade with denosumab in combination with sorafenib in chemorefractory osteosarcoma: a possible step forward?Richard Cathomas, Christian Rothermundt, Beata Bode, et al.
Anticancer Research|May 30, 2008
Identification of potential chemoresistance genes in osteosarcomaDenise Katherine Walters, Patrick Steinmann, Bettina Langsam, et al.
Cancers|October 14, 2023
Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency AnalysisMaria Elyes, Philip Heesen, Georg Schelling, et al.
Investigational New Drugs|April 27, 2007
Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell linesDenise K Walters, Roman Muff, Bettina Langsam, et al.
Pageof 18

Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Cancer|December 12, 2003
Complications in long-term survivors of Ewing sarcomaBruno Fuchs, Richard G Valenzuela, Carrie Inwards, et al.
BMC Cancer|August 3, 2014
ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2Ram Mohan Ram Kumar, Michael M Betz, Bernhard Robl, et al.
Molecular Carcinogenesis|August 9, 2007
Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasisKnut Husmann, Roman Muff, Marc E Bolander, et al.
Translational Oncology|April 28, 2017
Evaluation of F8-TNF-α in Models of Early and Progressive Metastatic OsteosarcomaBernhard Robl, Sander Martijn Botter, Aleksandar Boro, et al.
Clinical Orthopaedics and Related Research|October 16, 2008
Osteosarcoma of the pelvis: outcome analysis of surgical treatmentBruno Fuchs, Nathan Hoekzema, Dirk R Larson, et al.
Sarcoma|December 6, 2012
Genes regulated in metastatic osteosarcoma: evaluation by microarray analysis in four human and two mouse cell line systemsRoman Muff, Ram Mohan Ram Kumar, Sander M Botter, et al.
Oncology|December 23, 2014
RANK ligand blockade with denosumab in combination with sorafenib in chemorefractory osteosarcoma: a possible step forward?Richard Cathomas, Christian Rothermundt, Beata Bode, et al.
Anticancer Research|May 30, 2008
Identification of potential chemoresistance genes in osteosarcomaDenise Katherine Walters, Patrick Steinmann, Bettina Langsam, et al.
Cancers|October 14, 2023
Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency AnalysisMaria Elyes, Philip Heesen, Georg Schelling, et al.
Investigational New Drugs|April 27, 2007
Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell linesDenise K Walters, Roman Muff, Bettina Langsam, et al.
Pageof 18